格隆汇2月12日丨澳至尊(02031.HK)发布公告，自2026年2月12日起，公司的独立非执行董事彭倩薇获委 任为提名委员会成员。 ...

澳至尊(02031)发布公告，自2026年2月12日起，公司的独立非执行董事彭倩薇女士获委任为公司提名委 员会成员。 ...

Ausupreme International Holdings Limited 澳至尊國際控股有限公司 （於開曼群島註冊成立的有限公司） （「本公司」） 股份代號：2031 提名委員會 職權範圍 澳至尊國際控股有限公司（「本公司」）於2016年9月12日於香港聯合交易所有限公司 （「聯交所」）主板上市。 為遵守聯交所頒佈的企業管治守則的守則條文，本公司須成立提名委員會（「委員 會」）並制定及採納本文所載的職權範圍。 章程 1. 委員會根據本公司董事會（「董事會」及董事會的每位董事「董事」）於2016年7月 20日通過的決議案成立。 成員 會議次數及會議程序 5. 除本文另有註明外，委員會的會議將依照本公司組織章程大綱及組織章程細則 中規管董事會議及程序的條文進行。 – 1 – 2026年2月 2. 董事會將不時在董事中委任委員會之成員。委員會之成員數目將不少於三名， 當中獨立非執行董事應佔大多數。本委員會中至少有一名成員的性別應與其他 成員不同。 3. 委員會之主席須由董事會主席或一名獨立非執行董事擔任。 4. 委員會成員的任期應由董事會釐定。 股東週年大會 權力 – 2 – 2026年2月 6. 委員會須 ...

澳至尊國際控股有限公司 Ausupreme International Holdings Limited 執行董事 （於開曼群島註冊成立的有限公司） （股份代號：2031） 董事名單與其角色及職能 澳至尊國際控股有限公司董事會（「董事會」）成員載列如下： 尹祖伊 彭倩薇 本公司設有三個董事會委員會。下表載列董事會成員在該等委員會中所擔任之職務 資料： | 董事 | 審核委員會 | 薪酬委員會 | 提名委員會 | | --- | --- | --- | --- | | 蔡志輝 | | 成員 | 成員 | | 何家敏 | | | | | 陸定光 | 成員 | | 主席 | | 尹祖伊 | 成員 | 主席 | 成員 | | 彭倩薇 | 主席 | 成員 | 成員 | 香港，2026年2月12日 蔡志輝 （主席兼聯席行政總裁） 何家敏 （副主席兼聯席行政總裁） 獨立非執行董事 陸定光 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對就因本公佈全部或任 何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Ausupreme International Holdings Limited 澳至尊國際控股有限公司 （於開曼群島註冊成立的有限公司） 澳至尊國際控股有限公司（「本公司」）之董事會（分別為「董事會」及「董事」）公佈，自 二零二六年二月十二日起，本公司之獨立非執行董事彭倩薇女士獲委任為本公司提 名委員會（「提名委員會」）成員。 於上述委任後，提名委員會現包括一名不同性別的成員，並繼續由大多數獨立非執 行董事所組成。提名委員會由一名執行董事（即蔡志輝先生），以及三名獨立非執行 董事（即陸定光教授、尹祖伊博士及彭倩薇女士）組成。 承董事會命 （股份代號：2031） 提名委員會組成之變動 澳至尊國際控股有限公司 主席、執行董事及聯席行政總裁 蔡志輝 香港，二零二六年二月十二日 於本公告日期，董事會包括兩名執行董事，即蔡志輝先生（主席兼聯席行政總裁）及 何家敏女士（副主席兼聯席行政總裁）；以及三名獨立非執行 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 FF301 II. 已發行股份及/或庫存股份變動及足夠公眾持股量的確認 致：香港交易及結算所有限公司 公司名稱: 澳至尊國際控股有限公司 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02031 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 澳至尊國際控股有限公司 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02031 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 762,000,000 | | 0 | | 762,000,000 | | 增加 / 減少 (-) | | | | | | | | | 本月底結存 | | | 762,000,000 | | 0 | | 762,000,000 | 第 2 頁 共 10 頁 v 1.1.1 III.已發行股份及/或庫存股 ...

Ausupreme International Holdings Limited 澳至尊國際控股有限公司 (Incorporated in the Cayman Islands with limited liability) N OT IF IC ATI ON LET TE R 通 知 信 函 Dear Non-registered Shareholder(Note 1) , Ausupreme International Holdings Limited (the "Company") – Notice of Publication of 2025/2026 Interim Report (the "Current Corporate Communication(s)") The English and Chinese versions of the Company's Current Corporate Communication (s) are available on the Company's website at www.ausupreme.com and the website of The S ...

Ausupreme International Holdings Limited N OT IF IC ATI ON LET TE R 通 知 信 函 23 December 2025 Dear Registered Shareholder, Ausupreme International Holdings Limited (the "Company") – Notice of Publication of 2025/2026 Interim Report (the "Current Corporate Communication(s)") The English and Chinese versions of the Company's Current Corporate Communication (s) are available on the Company's website at www.ausupreme.com and the website of The Stock Exchange of Hong Kong Limited (the "HKEx's website") at www.hke ...

Financial Performance - Revenue for the six months ended September 30, 2025, was HKD 144,972,000, representing a 14.6% increase from HKD 126,540,000 in the same period of 2024[9] - Gross profit for the same period was HKD 126,817,000, up from HKD 110,347,000, indicating a growth of 15%[9] - The net profit for the period was HKD 17,901,000, which is a 35.5% increase compared to HKD 13,239,000 in the previous year[9] - Basic earnings per share increased to HKD 2.35 from HKD 1.74, reflecting a growth of 35%[9] - Total comprehensive income for the period was HKD 18,461,000, compared to HKD 14,685,000 in the prior year, marking a 25.5% increase[9] - The company reported a pre-tax profit of HKD 21,681,000 for the six months ended September 30, 2025, compared to HKD 15,939,000 for the same period in 2024, representing a growth of 36.5%[14] - Revenue from health supplements increased to HKD 138,589,000, up 15.1% from HKD 120,398,000 in the previous year[19] - Total revenue for the six months reached HKD 144,972,000, a rise of 14.6% compared to HKD 126,540,000 in 2024[19] - The company's profit for the six months ended September 30, 2025, was HKD 17,901,000, compared to HKD 13,239,000 for the same period in 2024, representing a year-on-year increase of approximately 35.5%[35] Cash and Assets - Cash and cash equivalents as of September 30, 2025, were HKD 82,619,000, up from HKD 78,723,000, showing a growth of 4.5%[11] - The company’s cash and cash equivalents at the end of the period were HKD 82,619,000, compared to HKD 80,030,000 at the end of the previous year[14] - Accounts receivable as of September 30, 2025, stood at HKD 27,707,000, compared to HKD 21,064,000 as of March 31, 2025, marking an increase of about 31.7%[36] - As of September 30, 2025, the group's current assets net value was HKD 115,398,000, an increase from HKD 110,807,000 as of March 31, 2025[56] - The company's total liabilities as of September 30, 2025, were HKD 14,979,000, compared to HKD 14,337,000 as of March 31, 2025, indicating a slight increase of about 4.5%[39] Expenses and Costs - The company reported a decrease in financing costs to HKD 494,000 from HKD 562,000, a reduction of 12.1%[9] - Total tax expenses for the six months ended September 30, 2025, amounted to HKD 3,780,000, up from HKD 2,700,000 in 2024, reflecting a growth of about 40%[7] - Depreciation expenses for property, plant, and equipment totaled HKD 8,640,000, an increase from HKD 7,584,000 in the previous year, indicating an increase of approximately 13.9%[30] - Selling and distribution expenses increased by 11.2% to HKD 87,278,000, while general and administrative expenses rose by 15.1% to HKD 18,697,000[52] - The total amount of inventory costs recognized as expenses was HKD 18,155,000, compared to HKD 16,193,000 in 2024, reflecting an increase of approximately 12.1%[30] Inventory and Operations - Inventory increased to HKD 20,913,000 from HKD 19,057,000, reflecting a 9.7% rise[11] - The company continues to focus on the retail and wholesale of health and personal care products, with all revenue derived from this segment[22] - Sales from consignment counters increased by 16.1% to HKD 105,184,000, accounting for 72.5% of total revenue[51] - The company opened one additional specialty store, bringing the total to 19 stores and 68 consignment counters as of September 30, 2025[48] Shareholder Information - The company declared dividends amounting to HKD 15,240,000 during the period[12] - The company has not declared an interim dividend for the six months ended September 30, 2025, consistent with the previous year[31] - The weighted average number of ordinary shares used for calculating basic and diluted earnings per share remained constant at 762,000,000 for both 2025 and 2024[33] - As of September 30, 2025, Beatitudes holds 443,840,000 shares, representing 58.25% of the total issued shares of 762,000,000[69][70] - Gao Yuan holds 93,635,000 shares, accounting for 12.29% of the total issued shares[69][70] Corporate Governance - The audit committee has reviewed and supervised the group's financial reporting system and internal control procedures during the reporting period[82][83] - The company has complied with the corporate governance code requirements, except for the separation of the roles of chairman and CEO[77][79] - The board believes that having the chairman also serve as co-CEO is in the best interest of the group due to his extensive knowledge and network in the industry[79] - The company has maintained a public float of at least 25% of its total issued shares throughout the reporting period[81] Strategic Initiatives - The company plans to continue optimizing its business strategy to adapt to the changing business environment[48] - The group plans to adopt digital and technological transformation to optimize operational processes and enhance efficiency[65] - The strategy includes expanding product diversity to meet the preferences of different customer segments[65] - The group aims to leverage the government's initiatives to attract more visitors to Hong Kong, which is expected to boost the overall retail market[65] Miscellaneous - The company has not granted any stock options since the adoption of the stock option plan on September 12, 2016, and there are no unexercised options as of September 30, 2025[72][73] - The company did not redeem any of its listed securities during the reporting period, nor did it purchase or sell any such securities[74][75] - The group had no significant investments, acquisitions, or disposals in subsidiaries, associates, or joint ventures for the six months ended September 30, 2025[60] - The employee count was 222 as of September 30, 2025, down from 232 a year earlier[62] - The company expresses gratitude to shareholders, business partners, and customers for their continued support[84]